Pacira BioSciences (PCRX) Non-Current Deferred Tax Liability (2025 - 2026)

Pacira BioSciences' Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability fell 41.5% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 41.5% YoY), while the FY2025 annual figure was $4.2 million, changed N/A from the prior year.
• Non-Current Deferred Tax Liability was $4.1 million for Q1 2026 at Pacira BioSciences, down from $4.2 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $7.0 million in Q1 2025 to a low of $4.1 million in Q1 2026.